Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM [Phase 1, Phase 2]
A Phase 1/2 clinical trial in China evaluating autologous stem cell transplantation combined with BCMA CAR-T therapy for ultra high risk mul…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating the combination of leflunomide, pomalidomide, and dexamethasone for relapsed or refractory multiple myel…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma [Phase 2]
A Phase 2 clinical trial is exploring autologous stem cell transplant followed by maintenance with BCMA CAR-T cells and GPRC5D/CD3 BiTEs for…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating MRD-adaptive guided CAR-T immunotherapy in transplant-ineligible patients with multiple myeloma; the study is curre…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma [Phase 2]
This is an update on a Phase II clinical trial evaluating siltuximab for preventing or treating CRS/ICANs after CAR-T therapy in patients wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia [Phase 2]
A Phase 2 clinical trial evaluating autologous stem cell transplant (ASCT) followed by maintenance with BCMA CAR-T cells and GPRC5D/CD3 BiTE…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial (TG01/QS-21 vaccine) is evaluating a peptide vaccine with QS-21 adjuvant in high-risk smoldering multiple myeloma…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT [NA]
A completed clinical trial update from Case Comprehensive Cancer Center about a transplant wellness clinic for elderly or high-risk patients…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM) [Phase 2]
A Phase 2 study evaluating venetoclax in combination with carfilzomib and dexamethasone in relapsed or refractory multiple myeloma; the tria…
-
CLINICAL_TRIALS research · 2025-08-04Clinical Trial Update: A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities [Phase 2]
A Phase 2 clinical study evaluating a VRd-based regimen combined with CART-ASCT-CART2 in newly diagnosed multiple myeloma patients with p53 …
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: BCMA CAR-T for Dynamic High-risk Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating a BCMA-targeted CAR-T therapy for dynamic high-risk multiple myeloma, with recruitment ongoing in China.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma [Phase 2]
Clinical trial update for a Phase 2 study evaluating a VRd-based regimen followed by BCMA CAR-T therapy in transplant-ineligible patients wi…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial in China is comparing BCMA CAR-T therapy to autologous stem cell transplant in transplant-eligible patients with multiple my…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST) [Phase 2]
A Phase 2 clinical trial (GEM-AnitoFIRST) is evaluating the efficacy and safety of Anitocabtagene Autoleucel in participants with newly diag…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: 64Cu-LLP2A for Imaging Hematologic Malignancies [EARLY_Phase 1]
Phase 1 imaging trial evaluating 64Cu-LLP2A in hematologic malignancies is currently recruiting, targeting multiple myeloma and various lymp…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) [NA]
Clinical trial update for ACT evaluating compassionate communication and advance care planning to improve end-of-life care in hematologic di…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients
This clinical trial update describes a study evaluating positron emission tomography with innovative laboratory techniques to improve risk a…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients [NA]
A clinical trial update notes an active, non-recruiting study evaluating a mobile app for education based on Orem's Self-Care Model in patie…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma [NA]
This clinical trial update examines two methods for collecting electronic patient-reported outcomes in patients with multiple myeloma. The s…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
This clinical trial update assesses the immune response to an RSV vaccine in patients with hematologic cancers, including multiple myeloma, …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM [Phase 1, Phase 2]
A clinical trial update describes a sub-study of belantamab mafodotin in combination with nirogacestat for relapsed and refractory multiple …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research [EARLY_Phase 1]
This document reports an EARLY Phase 1 clinical trial evaluating Meta10-BCMA for relapsed/refractory plasma cell neoplasms. The therapy uses…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant [NA]
This study update notes that a trial investigating cognitive outcomes in older adults receiving stem cell transplant is currently in RECRUIT…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03) [Phase 3]
A Phase III clinical trial evaluating Eque-cel for len-refractory relapsed/refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM [Phase 2]
Phase 2 trial evaluating subcutaneous daratumumab with dose-attenuated bortezomib, lenalidomide, and dexamethasone in elderly patients with …